← SynDRA
GEMIGLIPTIN
SynDRA canonical compound SYN0038437 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | DPP4 |
| Mechanism of action | dipeptidyl peptidase inhibitor |
All known targets
Mechanisms of action (all sources)
- DPP4 inhibitor
- dipeptidyl peptidase inhibitor
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- zemiglo
- LC15-0444
- Gemigliptine
- Gemigliptina
- LC-15-0444
- LC-150444
- LCD15-0444
- Dipeptidyl peptidase IV inhibitors (oral, type 2 diabetes), LG Life Sciences
- UNII-5DHU18M5D6
- 5DHU18M5D6
- (S)-1-(2-Amino-4-(2,4-bis(trifluoromethyl)-5,6-dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-4-oxobutyl)-5,5-difluoropiperidin-2-one
- (S)-1-(2-amino-4-(2,4-bis(trifluoromethyl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)-4-oxobutyl)-5,5-difluoropiperidin-2-one
- Gemigliptin [INN]
- Gemigliptin (prop.INN)
- SCHEMBL1262740
- CHEMBL3707235
- CHEBI:134731
- ZINC68245464
- AKOS025290873
- PB11419
- DB12412
- API0013914
- AK170799
- 2-Piperidinone, 1-((2S)-2-amino-4-(5,8-dihydro-2,4-
- gemigliptinum
- RefChem:639808
- A10BH06
- DTXCID001515258
- Gemigliptin Hydrochloride
- MFCD19443742
- Gemigliptin (INN)
- Gemigliptin?
- GEMIGLIPTIN [WHO-DD]
- orb1299878
- SCHEMBL29356288
- C18H19F8N5O2
- ZWPRRQZNBDYKLH-VIFPVBQESA-N
- BDBM664710
Look up GEMIGLIPTIN in the interactive SynDRA portal →